OPHTHOTECH CORP's ticker is OPHT and the CUSIP is 683745103. A total of 184 filers reported holding OPHTHOTECH CORP in Q2 2016. The put-call ratio across all filers is 1.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $4,013,000 | +22.9% | 86,992 | +36.0% | 0.01% | +16.7% |
| Q2 2016 | $3,265,000 | +20.5% | 63,987 | -0.2% | 0.01% | +20.0% |
| Q1 2016 | $2,709,000 | -58.5% | 64,092 | -22.9% | 0.01% | -58.3% |
| Q4 2015 | $6,531,000 | +26.1% | 83,168 | -35.0% | 0.02% | +14.3% |
| Q3 2015 | $5,181,000 | – | 127,870 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 1,103,981 | $44,734,000 | 25.02% |
| Novo Holdings A/S | 4,910,487 | $198,973,000 | 20.56% |
| JHL Capital Group LLC | 3,265,000 | $132,298,000 | 14.62% |
| AlpInvest Partners B.V. | 111,519 | $4,519,000 | 8.90% |
| Opaleye Management Inc. | 105,000 | $4,255,000 | 2.09% |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 16,110 | $653,000 | 2.05% |
| IMA Wealth, Inc. | 66,061 | $2,623,000 | 1.66% |
| WILLIAM HARRIS INVESTORS INC | 143,022 | $5,795,000 | 1.64% |
| Orbimed Advisors | 1,923,500 | $77,940,000 | 0.79% |
| Overbrook Management Corp | 117,807 | $4,774,000 | 0.74% |